YKL-40/CHI3L1 drives inflammation on the road of tumor progression (original) (raw)

Abstract

Inflammation plays a vital role at different stages of tumor progression. The development of tumors is affected by inflammatory mediators produced by the tumor and the host. YKL-40/chitinase-3-like-1 protein is often upregulated in inflammation-associated diseases. With the use of chronic inflammatory disease systems, we describe the role of YKL-40/chitinase-3-like-1 protein in enhancing the inflammatory response and its implications in tumorigenesis. We also discuss how pre-existing inflammation enhances tumor growth and metastasis. In this mini-review, we highlight the effect of YKL-40/ chitinase-3-like-1 protein-associated inflammation in promoting tumor progression.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (62)

  1. Hanahan, D., Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
  2. Balkwill, F., Coussens, L. M. (2004) Cancer: an inflammatory link. Nature 431, 405-406.
  3. Perwez Hussain, S., Harris, C. C. (2007) Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121, 2373-2380.
  4. Mantovani, A., Allavena, P., Sica, A., Balkwill, F. (2008) Cancer-related inflammation. Nature 454, 436-444.
  5. Coussens, L. M., Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
  6. Mantovani, A. (2009) Cancer: inflaming metastasis. Nature 457, 36-37.
  7. Hanahan, D., Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
  8. Johansen, J. S., Christensen, I. J., Riisbro, R., Greenall, M., Han, C., Price, P. A., Smith, K., Br ünner, N., Harris, A. L. (2003) High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res. Treat. 80, 15-21.
  9. Johansen, J. S., Drivsholm, L., Price, P. A., Christensen, I. J. (2004) High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 46, 333-340.
  10. Kzhyshkowska, J., Mamidi, S., Gratchev, A., Kremmer, E., Schmuttermaier, C., Krusell, L., Haus, G., Utikal, J., Schledzewski, K., Scholtze, J., Goerdt, S. (2006) Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107, 3221-3228.
  11. Libreros, S., Garcia-Areas, R., Shibata, Y., Carrio, R., Torroella-Kouri, M., Iragavarapu-Charyulu, V. (2012) Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model. Int. J. Cancer 131, 377-386.
  12. Owen, J. L., Iragavarapu-Charyulu, V., Gunja-Smith, Z., Herbert, L. M., Grosso, J. F., Lopez, D. M. (2003) Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J. Immunol. 171, 4340-4351.
  13. Owen, J. L., Lopez, D. M., Grosso, J. F., Guthrie, K. M., Herbert, L. M., Torroella-Kouri, M., Iragavarapu-Charyulu, V. (2005) The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor- derived factors. Cell. Immunol. 235, 122-135.
  14. Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl, J., Marti, G., Ptaszynski, K., Wang, J., Stetler-Stevenson, W. G. (1997) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 89, 1708-1715.
  15. Lugowska, I., Kowalska, M., Fuksiewicz, M., Kotowicz, B., Mierzejewska, E., Kosela-Paterczyk, H., Szamotulska, K., and Rutkowski, P. (2015) Serum markers in early-stage and locally advanced melanoma. Tumour Biol. DOI: 10.1007/s13277-015-3564-2.
  16. Libreros, S., Garcia-Areas, R., Iragavarapu-Charyulu, V. (2013) CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors. Immunol. Res. 57, 99-105.
  17. Létuvé, S., Kozhich, A., Arouche, N., Grandsaigne, M., Reed, J., Dombret, M. C., Kiener, P. A., Aubier, M., Coyle, A. J., Pretolani, M. (2008) YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J. Immunol. 181, 5167-5173.
  18. Noy, R., Pollard, J. W. (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49-61.
  19. Mantovani, A., Germano, G., Marchesi, F., Locatelli, M., Biswas, S. K. (2011) Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur. J. Immunol. 41, 2522-2525.
  20. Chong, H., Vodovotz, Y., Cox, G. W., Barcellos-Hoff, M. H. (1999) Immunocytochemical localization of latent transforming growth factor- beta1 activation by stimulated macrophages. J. Cell. Physiol. 178, 275-283.
  21. Ganapathy, V., Ge, R., Grazioli, A., Xie, W., Banach-Petrosky, W., Kang, Y., Lonning, S., McPherson, J., Yingling, J. M., Biswas, S., Mundy, G. R., Reiss, M. (2010) Targeting the transforming growth factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol. Cancer 9, 122.
  22. Wang, H., Lathia, J. D., Wu, Q., Wang, J., Li, Z., Heddleston, J. M., Eyler, C. E., Elderbroom, J., Gallagher, J., Schuschu, J., MacSwords, J., Cao, Y., McLendon, R. E., Wang, X. F., Hjelmeland, A. B., Rich, J. N. (2009) Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27, 2393-2404.
  23. Dubinett, S. M., Lee, J. M., Sharma, S., Mulé, J. J. (2010) Chemokines: can effector cells be redirected to the site of the tumor? Cancer J. 16, 325-335.
  24. Boimel, P. J., Smirnova, T., Zhou, Z. N., Wyckoff, J., Park, H., Coniglio, S. J., Qian, B. Z., Stanley, E. R., Cox, D., Pollard, J. W., Muller, W. J., Condeelis, J., Segall, J. E. (2012) Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res. 14, R23.
  25. Kawada, M., Seno, H., Kanda, K., Nakanishi, Y., Akitake, R., Komekado, H., Kawada, K., Sakai, Y., Mizoguchi, E., Chiba, T. (2012) Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 31, 3111-3123.
  26. Shao, R. (2013) YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front. Physiol. 4, 122.
  27. Shao, R., Hamel, K., Petersen, L., Cao, Q. J., Arenas, R. B., Bigelow, C., Bentley, B., Yan, W. (2009) YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene 28, 4456-4468.
  28. Francescone, R., Ngernyuang, N., Yan, W., Bentley, B., Shao, R. (2014) Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis. Oncogene 33, 2110-2122.
  29. Libreros, S., Garcia-Areas, R., Keating, P., Carrio, R., Iragavarapu- Charyulu, V. L. (2013) Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice. Front. Physiol. 4, 392.
  30. Shao, R., Francescone, R., Ngernyuang, N., Bentley, B., Taylor, S. L., Moral, L., Yan, W. (2014) Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma. Carcinogenesis 35, 373-382.
  31. Libreros, S., Garcia-Areas, R., Keating, P., Gazaniga, N., Robinson, P., Humbles, A., Iragavarapu-Charyulu, V. L. (2015) Allergen induced pulmonary inflammation enhances mammary tumor growth and metastasis: role of CHI3L1. J. Leukoc. Biol. 97, 929-940.
  32. Ma, B., Herzog, E. L., Lee, C. G., Peng, X., Lee, C. M., Chen, X., Rockwell, S., Koo, J. S., Kluger, H., Herbst, R. S., Sznol, M., Elias, J. A. (2015) Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis. Cancer Res. 75, 487-496.
  33. To, T., Stanojevic, S., Moores, G., Gershon, A. S., Bateman, E. D., Cruz, A. A., Boulet, L. P. (2012) Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 12, 204.
  34. Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., Kay, A. B. (1992) Predominant TH2- like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304.
  35. Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., Elias, J. A. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103, 779-788.
  36. Zhu, Z., Zheng, T., Homer, R. J., Kim, Y. K., Chen, N. Y., Cohn, L., Hamid, Q., Elias, J. A. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304, 1678-1682.
  37. Lee, C. G., Hartl, D., Lee, G. R., Koller, B., Matsuura, H., Da Silva, C. A., Sohn, M. H., Cohn, L., Homer, R. J., Kozhich, A. A., Humbles, A., Kearley, J., Coyle, A., Chupp, G., Reed, J., Flavell, R. A., Elias, J. A. (2009) Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J. Exp. Med. 206, 1149-1166.
  38. He, C. H., Lee, C. G., Dela Cruz, C. S., Lee, C. M., Zhou, Y., Ahangari, F., Ma, B., Herzog, E. L., Rosenberg, S. A., Li, Y., Nour, A. M., Parikh, C. R., Schmidt, I., Modis, Y., Cantley, L., Elias, J. A. (2013) Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor a2. Cell Reports 4, 830-841.
  39. Chen, C. C., Llado, V., Eurich, K., Tran, H. T., Mizoguchi, E. (2011) Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin. Immunol. 140, 268-275.
  40. Krishnamoorthy, S., Honn, K. V. (2006) Inflammation and disease progression. Cancer Metastasis Rev. 25, 481-491.
  41. Taranova, A. G., Maldonado III, D., Vachon, C. M., Jacobsen, E. A., Abdala-Valencia, H., McGarry, M. P., Ochkur, S. I., Protheroe, C. A., Doyle, A., Grant, C. S., Cook-Mills, J., Birnbaumer, L., Lee, N. A., Lee, J. J. (2008) Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res. 68, 8582-8589.
  42. Olkhanud, P. B., Rochman, Y., Bodogai, M., Malchinkhuu, E., Wejksza, K., Xu, M., Gress, R. E., Hesdorffer, C., Leonard, W. J., Biragyn, A. (2011) Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J. Immunol. 186, 5656-5662.
  43. Lee, C. G., Dela Cruz, C. S., Ma, B., Ahangari, F., Zhou, Y., Halaban, R., Sznol, M., Elias, J. A. (2012) Chitinase-like proteins in lung injury, repair, and metastasis. Proc. Am. Thorac. Soc. 9, 57-61.
  44. Brody, J. S., Spira, A. (2006) State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 3, 535-537.
  45. Raviv, S., Hawkins, K. A., DeCamp, Jr., M. M., Kalhan, R. (2011) Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. Am. J. Respir. Crit. Care Med. 183, 1138-1146.
  46. Mannino, D. M., Aguayo, S. M., Petty, T. L., Redd, S. C. (2003) Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up. Arch. Intern. Med. 163, 1475-1480.
  47. Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., Paré, P. D. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653.
  48. Houghton, A. M. (2013) Mechanistic links between COPD and lung cancer. Nat. Rev. Cancer 13, 233-245.
  49. Holmgaard, D. B., Mygind, L. H., Titlestad, I. L., Madsen, H., Pedersen, S. S., Johansen, J. S., Pedersen, C. (2013) Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. BMC Pulm. Med. 13, 77.
  50. Matsuura, H., Hartl, D., Kang, M. J., Dela Cruz, C. S., Koller, B., Chupp, G. L., Homer, R. J., Zhou, Y., Cho, W. K., Elias, J. A., Lee, C. G. (2011) Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema. Am. J. Respir. Cell Mol. Biol. 44, 777-786.
  51. Molodecky, N.A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., Kaplan, G. G. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54.e42; quiz e30.
  52. Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., Forbes, A. (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126, 451-459.
  53. Gupta, R. B., Harpaz, N., Itzkowitz, S., Hossain, S., Matula, S., Kornbluth, A., Bodian, C., Ullman, T. (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133, 1099-1105, quiz 1340-1341.
  54. Fukata, M., Chen, A., Vamadevan, A. S., Cohen, J., Breglio, K., Krishnareddy, S., Hsu, D., Xu, R., Harpaz, N., Dannenberg, A. J., Subbaramaiah, K., Cooper, H. S., Itzkowitz, S. H., Abreu, M. T. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869-1881.
  55. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G. Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., Karin, M. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103-113.
  56. Sethi, G., Sung, B., Aggarwal, B. B. (2008) TNF: a master switch for inflammation to cancer. Front. Biosci. 13, 5094-5107.
  57. Tran, H. T., Lee, I. A., Low, D., Kamba, A., Mizoguchi, A., Shi, H. N., Lee, C. G., Elias, J. A., Mizoguchi, E. (2014) Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis. Inflamm. Bowel Dis. 20, 835-846.
  58. Mizoguchi, E. (2006) Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology 130, 398-411.
  59. Chen, C. C., Pekow, J., Llado, V., Kanneganti, M., Lau, C. W., Mizoguchi, A., Mino-Kenudson, M., Bissonnette, M., Mizoguchi, E. (2011) Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am. J. Pathol. 179, 1494-1503.
  60. Kawada, M., Hachiya, Y., Arihiro, A., Mizoguchi, E. (2007) Role of mammalian chitinases in inflammatory conditions. Keio J. Med. 56, 21-27.
  61. Mager, D. L. (2006) Bacteria and cancer: cause, coincidence or cure? A review. J. Transl. Med. 4, 14.
  62. KEY WORDS: angiogenesis • inflammatory bowel • pulmonary inflammation • cytokines